PACIRA BIOSCIENCES INC (PCRX)
Sector: Health Care
Sector: Health Care
PACIRA BIOSCIENCES INC - Executive Compensation
Chief Financial Officer
Executive Compensation
Shawn Cross serves as the Chief Financial Officer at Pacira BioSciences Inc., a position he has held since joining the company in 2019. With a robust background in finance and strategic planning, Cross has been instrumental in steering Pacira BioSciences towards sustained growth and profitability. Before joining Pacira, he held the position of CFO at Endo International plc, where he played a pivotal role in enhancing the company's financial performance and operational efficiency. His career also includes significant tenures at InVentiv Health and Cardinal Health, where he developed a reputation for his strategic financial acumen and leadership. At Pacira BioSciences, Cross is responsible for overseeing the company's financial strategies, including budgeting, forecasting, and financial reporting. Under his leadership, Pacira has successfully navigated the complexities of the pharmaceutical industry, particularly in the realm of non-opioid pain management solutions. One of his notable achievements at Pacira includes the successful refinancing of the company's debt, which improved its financial flexibility and positioned it for future growth. Cross's strategic vision and financial expertise have been crucial in driving Pacira's mission to provide innovative medical solutions that improve patient outcomes. In addition to his professional responsibilities, Shawn Cross is known for his commitment to fostering a culture of transparency and accountability within Pacira BioSciences. His leadership style emphasizes collaboration and innovation, encouraging his team to think creatively about financial challenges and opportunities. Cross holds a Bachelor of Science in Business Administration from the University of Pittsburgh and an MBA from the Wharton School of the University of Pennsylvania. His educational background, combined with his extensive experience, makes him a vital asset to Pacira BioSciences as they continue to expand their footprint in the healthcare industry.